Nav: Home

China faces science reform challenges, including favoritism

March 09, 2017

In this Policy Forum, Cong Cao and Richard P. Suttmeier highlight the immense work and challenges China will encounter as it attempts to reform its scientific and technological (S&T) development strategy. A related Perspective highlights issues of favoritism in Chinese research that pose an additional difficulty in this arena. Advances in China's S&T policy space have surged over the past decades, yet recently, Chi­nese political leaders became concerned that this forward momentum was more "technological catch-up" than genuine innovation. Therefore, policies since 2013 have intended to radically reform the nation's research institu­tions and broader innovation system. Under a new financial scheme, the nation's S&T programs have been reorganized to use gov­ernment R&D expenditures more efficiently and to complete the translation of research to commercialization more effectively. The country has undergone institutional and project management changes, including an initiative that reorganizes the Chinese Academy of Science's more than 100 institutes into four ma­jor thematic categories. In terms of technology transfer, the Chinese government has also approved policy that would allow aca­demics greater freedom to do part-time work with companies. Despite these promising reforms, the authors note that the autonomy of the resulting committees, institutions and other bodies is unclear. The reforms subject sci­entists to organizational churn that may be counterproductive, Cao and Suttmeier say, concluding that whether these approaches will function well within the framework of Chinese political landscape remains to be seen.

In a related Perspective, Yu Xie focuses on a recent study showing that election of membership to the two most prestigious sci­entific organizations in China appears to be influ­enced by "guanxi," essentially a person's social network associated with their hometown. The study found that sharing the same place of origin with selection committee members boosts a candidate's probability of election success by about 40%. Xie notes that similar favoritism in science has been found in studies of other cultures, and emphasizes that this latest work "remind[s] us that science is ultimately a social institution affecting, and affected by, human behavior."
-end-


American Association for the Advancement of Science

Related Research Articles:

More Research News and Research Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at Radiolab.org/donate.